Oligonucleotide Pool Market Research Report - Global Forecast till 2027

Oligonucleotide Pool Market Research Report: Information by Type (DNA and RNA), Application (Research, Diagnostics & Therapeutics and other), End User (Commercial Research, Pure Academic Research and other) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/LS/1916-CR | August 2019 | Region: Global | 110 Pages         

1 Report Prologue

2 Market Introduction

2.1 Definition 13

2.2 Scope of Study 13

2.3 Research Objective 13

2.4 Assumptions & Limitations 14

2.4.1 Assumptions 14

2.4.2 Limitations 14

2.5 Market Structure 14

3 Research Methodology

3.1 Primary Research Methodology 16

3.2 Secondary Research Methodology 18

3.3 Market Size Estimation 19

3.4 Forecast Model 19

4 Market Dynamics

4.1 Introduction 21

4.2 Drivers 21

4.2.1 Big Pharmaceutical Companies Investing in Oligonucleotide Therapeutics for Drug Development 22

4.2.2 Increased Involvement of CMOs in Manufacturing Therapeutic Oligonucleotides 22

4.2.3 Wide Application Areas Offered by the Oligonucleotides 23

4.3 Restraints 23

4.3.1 Complexity in the Manufacturing Technique and Inaccuracy of Oligonucleotides 23

4.4 Opportunities 23

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 25

5.1.1 Bargaining Power of Suppliers 26

5.1.2 Bargaining Power of Buyers 26

5.1.3 Threat of New Entrants 26

5.1.4 Threat of Substitutes 26

5.1.5 Intensity of Rivalry 26

6 Oligonucleotide Pool Market, by Type

6.1 Introduction 28

6.2 DNA 29

6.3 RNA 29

7 Oligonucleotide Pool Market, by Application

7.1 Introduction 31

7.2 Research 33

7.3 Diagnostics & Therapeutics 33

7.4 Other 33

8 Oligonucleotide Pool Market, by End User

8.1 Introduction 35

8.2 Commercial Research 37

8.3 Pure Academic Research 37

8.4 Other 37

9 Global Oligonucleotide Pool Market, by Region

9.1 Introduction 39

9.2 North America 40

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.2.1 US. 43

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.2.2 Canada 44

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3 Europe 45

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.1 Germany 47

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.2 France 48

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.3 UK. 49

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.4 Italy 50

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.5 Spain 51

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.6 Rest of Western Europe 52

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.3.7 Eastern Europe 53

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4 Asia-Pacific 54

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.1 Australia 57

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.2 Japan 57

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.3 China 58

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.4 India 59

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.4.5 Rest of Asia-Pacific 60

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.5 Middle East & Africa 61

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.5.1 Middle East 63

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

9.5.2 Africa 64

Oligonucleotide Pool Market, by Type

Oligonucleotide Pool Market, by Application

Oligonucleotide Pool Market, by End User

10 Competitive Landscape

10.1 Introduction 66

11 Company Profiles

11.1 Sigma-Aldrich Co. LLC 68

11.1.1 Company Overview 68

11.1.2 Financial Overview 68

11.1.3 Product Offered 69

11.1.4 4 Key Developments 69

11.1.5 SWOT Analysis 69

11.1.6 Key Strategies 69

11.2 Twist Bioscience 70

11.2.1 Company Overview 70

11.2.2 Financial Overview 70

11.2.3 Product Offered 70

11.2.4 Key Developments 70

11.2.5 SWOT Analysis 71

11.2.6 Key Strategies 71

11.3 MYcroarray 72

11.3.1 Company Overview 72

11.3.2 Financial Overview 72

11.3.3 Treatments Offered 72

11.3.4 1.3.3 Key Developments 72

11.3.5 SWOT Analysis 72

11.3.6 Key Strategies 72

11.4 TriLink BioTechnologies, LLC 73

11.4.1 Company Overview 73

11.4.2 Financial Overview 73

11.4.3 Products Offered 73

11.4.4 Key Developments 73

11.4.5 SWOT Analysis 74

11.4.6 Key Strategies 74

11.5 Agilent Technologies 75

11.5.1 Company Overview 75

11.5.2 Financial Overview 75

11.5.3 Products Offered 76

11.5.4 Key Developments 76

11.5.5 SWOT Analysis 76

11.5.6 Key Strategies 76

11.6 Creative Biogene 77

11.6.1 Company Overview 77

11.6.2 Financial Overview 77

11.6.3 Products Offered 77

11.6.4 Key Developments 77

11.6.5 SWOT Analysis 78

11.6.6 Key Strategies 78

11.7 CustomArray, Inc. 79

11.7.1 Company Overview 79

11.7.2 Financial Overview 79

11.7.3 Products Offered 79

11.7.4 Key Developments 79

11.7.5 SWOT Analysis 79

11.7.6 Key Strategies 79

11.8 Integrated DNA Technologies, Inc. 80

11.8.1 Company Overview 80

11.8.2 Financial Overview 80

11.8.3 Products Offered 80

11.8.4 Key Developments 81

11.8.5 SWOT Analysis 81

11.8.6 Key Strategies 81

12 Appendix

12.1 Discussion Blue Print 83

13 List of Tables

TABLE 1 PRIMARY INTERVIEWS 17

TABLE 2 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 29

TABLE 3 GLOBAL DNA OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2020–2027 (USD MILLION) 29

TABLE 4 GLOBAL RNA OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2020–2027 (USD MILLION) 29

TABLE 5 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 32

TABLE 6 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 32

TABLE 7 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR RESEARCH, BY REGION, 2020–2027 (USD MILLION) 33

TABLE 8 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR DIAGNOSTICS & THERAPEUTICS, BY REGION 2020–2027 (USD MILLION) 33

TABLE 9 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR OTHER APPLICATIONS, BY REGION 2020–2027 (USD MILLION) 33

TABLE 10 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 36

TABLE 11 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR COMMERCIAL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 12 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR PURE ACADEMIC RESEARCH, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 13 GLOBAL OLIGONUCLEOTIDE POOL MARKET FOR OTHER END USER, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 14 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 15 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 41

TABLE 16 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 41

TABLE 17 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 42

TABLE 18 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 42

TABLE 19 US OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 43

TABLE 20 US OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 43

TABLE 21 US OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 43

TABLE 22 CANADA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 44

TABLE 23 CANADA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 44

TABLE 24 CANADA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 44

TABLE 25 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 46

TABLE 26 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 46

TABLE 27 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 46

TABLE 28 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 47

TABLE 29 GERMANY OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 30 GERMANY OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 47

TABLE 31 GERMANY OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 47

TABLE 32 FRANCE OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 48

TABLE 33 FRANCE OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 48

TABLE 34 FRANCE OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 48

TABLE 35 UK. OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 49

TABLE 36 UK OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 49

TABLE 37 UK OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 49

TABLE 38 ITALY OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 50

TABLE 39 ITALY OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 50

TABLE 40 ITALY OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 50

TABLE 41 SPAIN OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 51

TABLE 42 SPAIN OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 51

TABLE 43 SPAIN OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 51

TABLE 44 REST OF WESTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 45 REST OF WESTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 52

TABLE 46 REST OF WESTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 52

TABLE 47 EASTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 53

TABLE 48 EASTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 53

TABLE 49 EASTERN EUROPE OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 53

TABLE 50 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55

TABLE 51 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 52 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56

TABLE 53 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 56

TABLE 54 AUSTRALIA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 55 AUSTRALIA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 57

TABLE 56 AUSTRALIA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 57

TABLE 57 JAPAN OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 58 JAPAN OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 58

TABLE 59 JAPAN OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 58

TABLE 60 CHINA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 61 CHINA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 58

TABLE 62 CHINA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 59

TABLE 63 INDIA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 64 INDIA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59

TABLE 65 INDIA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 59

TABLE 66 REST OF ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 67 REST OF ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 60

TABLE 68 REST OF ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 60

TABLE 69 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2020–2027 (USD MILLION) 61

TABLE 70 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 71 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 72 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 62

TABLE 73 MIDDLE EAST OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 74 MIDDLE EAST OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 75 MIDDLE EAST OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 63

TABLE 76 AFRICA OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 77 AFRICA OLIGONUCLEOTIDE POOL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64

TABLE 78 AFRICA OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020–2027 (USD MILLION) 64

14 List of Figures

FIGURE 1 MARKET STRUCTURE OF THE GLOBAL OLIGONUCLEOTIDE POOL MARKET 14

FIGURE 2 TOP-DOWN AND BOTTOM-UP APPROACHES 19

FIGURE 3 MARKET DYNAMICS 21

FIGURE 4 PORTER’S FIVE FORCES MODEL 25

FIGURE 5 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 28

FIGURE 6 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY END-USER, 2020 & 2027 (USD MILLION) 36

FIGURE 7 GLOBAL OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2020 (%) 39

FIGURE 8 NORTH AMERICA OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2020 (%) 41

FIGURE 9 EUROPE OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2020 (%) 45

FIGURE 10 ASIA-PACIFIC OLIGONUCLEOTIDE POOL MARKET, BY COUNTRY, 2020 (%) 54

FIGURE 11 MIDDLE EAST & AFRICA OLIGONUCLEOTIDE POOL MARKET, BY REGION, 2020 (%) 61

FIGURE 12 GLOBAL OLIGONUCLEOTIDE POOL COMPANY SHARE, 2020 (%) 66

Oligonucleotide Pool Market

Oligonucleotide Pool Market is estimated to grow to reach USD 2,562.6 Million at a CAGR of 10.3% during forecast period

Segmentation

By Type Dna And Rna
Application Research Diagnostics & Therapeutics And Other
End User Commercial Research Pure Academic Research And Other

Key Players

  • CustomArray Inc. (US)
  • Sigma-Aldrich Co. LLC (US)
  • Integrated DNA Technologies Inc. (US)
  • Twist Bioscience (US)
  • Creative Biogene (US)
  • Agilent Technologies (US)
  • TriLink BioTechnologies Inc. (US)
  • Arbon Biosciences (US)
  • Illumina (US)
  • Eurofins Genomics (Germany)
  • G.C. Biosearch Technologies (UK)

Drivers

  • huge investments by the pharmaceutical companies
Speak to Analyst Request a Free Sample

Oligonucleotide Pool Market Overview


The Oligonucleotide Pool Market is estimated to grow at a CAGR of 10.3%. As a result, the market value will further register up to USD 2,562.6 Million by the end of the forecast period 2021-2028. The oligonucleotide sequencing is basically short nucleic acid polymers that are used for hybridizing RNA and DNA sequencing. The oligonucleotide drugs are manufactured in laboratories with the process called solid-phase chemical synthesis.  It is used for artificial gene synthesis, library construction and polymerase, and chain reaction.


Several drivers and market developments such as the high demand for oligonucleotide sequencing are expected to enhance the market growth. North America will hold the largest share in the Oligonucleotide Pool Market. Also, the market is divided into various segments such as type, application, and end-user. The investments by the large pharmaceutical companies and the growing demand for better healthcare facilities and treatment will enhance the market growth.


COVID-19 Analysis


The COVID-19 disease had a significant impact on the market. The lockdown for several months across the world causes huge financial strain. Due to this, many businesses had put shut down their manufacturing units. However, with the ease of lockdown restriction, several companies have come forward for collaboration and technological development in the Oligonucleotide Pool Market. Thus, the COVID-19 had a mixture of both positive and negative impacts on the market.


Global Oligonucleotide Pool Market Size, by End User, 2017 (USD Million)  Oligonucleotide Pool Market Source: MRFR Analysis


Market Dynamics


Market Drivers


The major market drivers that are projected to boost the market growth are the huge investments by the pharmaceutical companies for the development of oligonucleotide therapeutics. Along with that, the growing demand for point-of-care testing products will boost the market growth in the forthcoming years.


Restraints


There are some restraints such as the shift in the supply chains for saving costs, and the changing focus of customers will hamper the market growth. Along with that, the high costs related to drug manufacturing and other developments will also restrict the market growth.


Opportunities


Various opportunities are anticipated to boost the Oligonucleotide Pool Market. The major investments by the major pharmaceutical companies for the development and research for oligonucleotide therapeutics will open new opportunities for market growth. Also, new acquisitions and mergers by the key players are helping the market to grow.


Challenges


The low presence of skilled laborers is the major challenge for the growth of the Oligonucleotide Pool Market. Also, the disruption caused by the COVID-19 disease has led to a huge financial burden upon small-scale as well as large-scale companies. However, the market will regain its growth in the upcoming years.


Cumulative Analysis


The Compound Annual Growth Rate (CAGR) of the Oligonucleotide Pool Market is anticipated to reach up to 10.3%. According to MRFR analysis, the market value will touch up to USD 2,562 Million by the end of the forecast period 2021-2028. Hence, the market will have positive growth in the upcoming years with significant demand for antisense oligonucleotide therapy.


Value Chain Analysis


The value chain of the market is evaluated to grow to strengthen with gradual and significant growth. Various drivers, opportunities, such as the high demand for oligonucleotide therapy will increase in the forecast period. Despite the several restraints, the market will flourish with the effective growth in the value chain of the market.


Asia-Pacific Oligonucleotide Pool Market Share, by Country, 2017 (%)  Oligonucleotide Pool Market


Source: MRFR Analysis


Market Segmentations


The Oligonucleotide Pool Market segments are divided into end-user, application, and type. On the basis of type, the Oligonucleotide Pool Market is divided into RNA and DNA.


On the basis of application, the market is divided into therapeutics, and diagnostics, research, and others.


On the basis of end-user is segmented into pure academic research, commercial research, and others.


Regional Analysis


Regionally, the Oligonucleotide Pool Market is segmented into North America, Asia-Pacific, Europe, and the Middle East, and Africa. The MRFR analysis suggests that the North American region is evaluated to have the largest growth. It is mainly due to the presence of several manufacturers in the big-scale and small-scale industries in the countries such as the US and Canada. Also, the availability of several healthcare facilities such as diagnostic centers, state-of-the-art laboratories with technological advancements is promoting growth in this region.


Secondly, the European region holds the second position in the Oligonucleotide Pool Market. The rising development by the key players in genomics is fuelling market growth in the future. Also, supportive programs for drug administration for the approval of oligonucleotide therapeutics are a major reason for the growth.


Asia-Pacific region is anticipated to record the fastest growth in the forecast period. The rising developments for the research and developments in major countries such as India, Japan, China, etc. will further increase the value of the Oligonucleotide Pool Market. Along with that, the Middle East and African region will also have a gradual growth with the improvement in the healthcare facilities.


Competitive Landscape


The key players help to promote the growth of the Oligonucleotide Pool Market. They do mergers, product launches, collaborations, joint ventures, acquisitions, etc. These strategies help the key players to expand their business portfolio. These are some notable key players in the Oligonucleotide Pool Market.



  • CustomArray Inc. (US)

  • Sigma-Aldrich Co. LLC (US)

  • Integrated DNA Technologies Inc. (US)

  • Twist Bioscience (US)

  • Creative Biogene (US)

  • Agilent Technologies (US)

  • TriLink BioTechnologies Inc. (US)

  • Arbon Biosciences (US)

  • Illumina (US)

  • Eurofins Genomics (Germany)

  • G.C. Biosearch Technologies (UK)


Recent Developments



  • Twist Bioscience in April 2019, announced the agreement of antibody optimization with a company called Pandion Therapeutics.

  • IDT in the year 2017 announced the launch of a service called RxnReady Oligo. This service will help the researchers to order several oligos for ready-to-use purposes easily.

  • In 2019, IDT announced its partnership with a company called ChosenMed. It is a Chinese firm that is expected to strengthen the company to become a leading company.

  • IDT announced the acquisition of an Australian company called GeneWorks.


Report Overview


The report overview of the Oligonucleotide Pool Market is as follows.



  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development


Report Score and Segmentation



  • Study Period- 2021-2028

  • Base Year-2021

  • Forecast Period- 2021-2028

  • Historical Period-2019-2020


The report score of the Oligonucleotide Pool Market is to give information about the different market dynamics such as opportunities, market value, challenges, etc. during the forecast period 2021-2028. The information provided in this report is collected from secondary and primary sources.


Segmentation



  • By Type

  • RNA

  • DNA



  • By End User

  • Pure Academic Research

  • Commercial Research

  • Others



  • By Application

  • Therapeutics and Diagnostics

  • Research



  • By Region

  • North America

  • Asia-Pacific

  • Europe

  • Latin America

  • The Middle East and Africa


 



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 2,562.6 Million
  CAGR   10.3% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Application, End User and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Sigma-Aldrich Co. LLC (US), Twist Bioscience (US), Arbor Biosciences (US), TriLink BioTechnologies, Inc. (US), Agilent Technologies (US), Creative Biogene (US), CustomArray, Inc. (US), Integrated DNA Technologies, Inc. (US)
  Key Market Opportunities   Rising demand in genomics and proteomics
  Key Market Drivers   Increase in demand for point of care testing products


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Oligonucleotide pool market projected to grow at approximately 10.3% CAGR during the assessment period (2017-2023).

The valuation of the global oligonucleotide pool market is estimated to increase to USD 2,562.6 MN by the end of 2023.

Rise of peptide drugs & research on them and wide acceptance of proteinaceous therapeutics are major tailwinds pushing the growth of the global oligonucleotide pool market.

North America holds the largest share in the global oligonucleotide pool market, followed by Europe and the Asia Pacific, respectively.

Twist Bioscience (US), CustomArray, Inc. (US), Sigma-Aldrich Co. LLC (US), Integrated DNA Technologies, Inc. (US), Arbor Biosciences (US), Creative Biogene (US), Agilent Technologies (US), and TriLink BioTechnologies, Inc. (US), are some of the top players operating in the global oligonucleotide pool market.